US20090187139A1 - Peritoneal dialysis system - Google Patents

Peritoneal dialysis system Download PDF

Info

Publication number
US20090187139A1
US20090187139A1 US12/278,662 US27866207A US2009187139A1 US 20090187139 A1 US20090187139 A1 US 20090187139A1 US 27866207 A US27866207 A US 27866207A US 2009187139 A1 US2009187139 A1 US 2009187139A1
Authority
US
United States
Prior art keywords
tot
peritoneal dialysis
volume
processing means
cycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/278,662
Inventor
Diego Mastalli
Alfio Quarteroni
Paolo Zunino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Debiotech SA
Original Assignee
Debiotech SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiotech SA filed Critical Debiotech SA
Assigned to DEBIOTECH S.A. reassignment DEBIOTECH S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MASTALLI, DIEGO, QUARTERONI, ALFIO, ZUNINO, PAOLO
Publication of US20090187139A1 publication Critical patent/US20090187139A1/en
Priority to US14/250,345 priority Critical patent/US9471754B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/282Operational modes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/40ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient

Definitions

  • the present invention relates to a peritoneal dialysis system which can conduct a specific peritoneal dialysis treatment.
  • the invention also relates to a method for determining a peritoneal dialysis treatment which is specific for each patient.
  • a liquid the so called dialysate
  • the exchange takes place through the net of capillaries within the peritoneal membrane.
  • peritoneal dialysis system which comprises pumping means, therapy data receiving means and processing means, said processing means being designed to process said therapy data and to impart a switching sequence to said pumping means.
  • the system according to the invention is characterized by the fact that said processing means are furthermore designed to impart a specific exchange profile for each exchange cycle.
  • system according to the invention is designed to vary the exchange cycles during the treatment in order to better match the patient characteristics in a dynamic way.
  • DPD Dynamic Peritoneal Dialysis
  • the variation of the exchange cycles can be done in varying the injected volume of liquid and/or the dwell times and/or the extracted volume of liquid.
  • FIG. 1 illustrates the volume exchange with the peritoneal cavity.
  • FIG. 2 illustrates a state-of-the-art therapy
  • FIG. 3 illustrates a DPD treatment according to the invention.
  • T tot the total therapy time (T tot ), the total dialysate volume available for the peritonal dialysis session (V tot ), the flow rate of the pumping means (q), the maximum dialysate volume that can be contained in the peritoneal cavity (V max ), the minimum dialysate volume reachable in the peritoneal cavity (V min ) and the number of cycles of the therapy (N).
  • the DPD method provides the injection-dwell-extraction pattern taking into account a set of constraints:
  • the DPD strategy Based on the previous input data and constraints the DPD strategy provides the injection-dwell-extraction through the following iterative relations.
  • the first set is used to choose the dwell times T D(i) of the DPD pattern as follows:
  • the second set is used to choose the volumes injected DV(i) of the DPD pattern as follows
  • DT (k) represent the time needed in each cycle for the injection phase, the dwell and the extraction phase.

Landscapes

  • Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • External Artificial Organs (AREA)

Abstract

Peritoneal dialysis system comprising pumping means, therapy data receiving means and processing means, said processing means being designed to process said therapy data and to impart a switching sequence to said pumping means characterized by the fact that said processing means are furthermore designed to impart a specific exchange profile for each exchange cycle.

Description

    FIELD OF INVENTION
  • The present invention relates to a peritoneal dialysis system which can conduct a specific peritoneal dialysis treatment.
  • The invention also relates to a method for determining a peritoneal dialysis treatment which is specific for each patient.
  • STATE OF THE ART
  • During a peritoneal dialysis session a liquid, the so called dialysate, is introduced many times into the peritoneal cavity in order to exchange toxins and liquid with the blood. The exchange takes place through the net of capillaries within the peritoneal membrane.
  • Examples of standard treatments are:
      • APD (Automatic Peritoneal Dialysis),
      • CAPD (Continuous Ambulatory Peritoneal dialysis),
      • CCPD (Continuous Cycling Peritoneal Dialysis),
      • TPD (Tidal Peritoneal Dialysis).
  • All state of the art treatments are characterized by exchanges with fixed volumes and dwells. However, those treatments are not taking into account the permanent change of patient characteristics after each exchange cycle.
  • It would therefore be more efficient to have another treatment which better follow the changes of patient characteristics during a treatment.
  • DESCRIPTION OF THE INVENTION
  • The above cited problems are solved with the peritoneal dialysis system according to the invention which comprises pumping means, therapy data receiving means and processing means, said processing means being designed to process said therapy data and to impart a switching sequence to said pumping means. The system according to the invention is characterized by the fact that said processing means are furthermore designed to impart a specific exchange profile for each exchange cycle.
  • In other words, the system according to the invention is designed to vary the exchange cycles during the treatment in order to better match the patient characteristics in a dynamic way.
  • In the following text, the treatment according to the invention is called DPD for Dynamic Peritoneal Dialysis.
  • The variation of the exchange cycles can be done in varying the injected volume of liquid and/or the dwell times and/or the extracted volume of liquid.
  • A more detailed description of the invention is presented below together with the following figures:
  • FIG. 1 illustrates the volume exchange with the peritoneal cavity.
  • FIG. 2 illustrates a state-of-the-art therapy
  • FIG. 3 illustrates a DPD treatment according to the invention.
  • Let us introduce the notation that will be used in relation with the DPD pattern. We remind that the injection-dwell-extraction pattern in peritoneal dialysis (PD) is made by several cycles i=1, . . . , N (see FIG. 1). The Vmax and Vmin in FIG. 1 represent respectively the maximum volume that can be introduced in the peritoneal cavity and the minimum volume reachable. In each cycle some fresh dialysate is injected (DVi), and extracted from the patient after a given dwell time (TDi). We refer to FIG. 2 for an explanation of the notation. The standard therapies nowadays in use APD, CAPD, CCPD, TPD etc. . . . , have a common property: the dwell times DTi and the injected volumes DVi are fixed with respect the number of cycle i=1; . . . ; N. It means that:

  • DT(1)=DT(2)= . . . =DT(N)

  • DV(1)=DV(2)= . . . =DV(N)
  • This is just the case represented in FIG. 2. It is obvious that by this way the standard PD treatments are somewhat rigid because there is no possibility to get DT(1)≠DT(2)≠ . . . ≠DT(N) and or DV(1)≠DV(2)≠ . . . ≠DV(N). Conversely, the DPD treatments provide this possibility and guarantee more flexibility. We refer to FIG. 3 as example of DPD. The reader should recognize easily the variability in dwell times and volumes that distinguish DPD with respect standard therapies by a comparison of FIGS. 2 and 3.
  • In order to build a DPD pattern we consider a set of input data concerning the therapy.
  • Preferably we consider as input the total therapy time (Ttot), the total dialysate volume available for the peritonal dialysis session (Vtot), the flow rate of the pumping means (q), the maximum dialysate volume that can be contained in the peritoneal cavity (Vmax), the minimum dialysate volume reachable in the peritoneal cavity (Vmin) and the number of cycles of the therapy (N).
  • The DPD method provides the injection-dwell-extraction pattern taking into account a set of constraints:
      • the therapy begin filling the peritoneal cavity up to Vmax,
      • the therapy must not be longer than the fixed total time Ttot,
  • i = 1 N TD ( i ) = T tot - 2 V tot q
      • the total dialysate volume injected must be equal to the total amount Vtot available,
  • i = 1 N - 1 VD ( i ) = V tot - ( V max - V min )
      •  the dwell times must be positive,

  • TD(i)>0, i=1, . . . N
      • the volume of dialysate into the peritoneal cavity must respect the lower and the upper bounds Vmin and Vmax

  • 0<DV(i)≦V max −V min, i=1, . . . , N−1
      • the therapy end emptying the peritoneal cavity from Vmax to Vmin,
      • Nmin is the minimum number of cycles needed to use the dialysate available: Nmin=ceil(Vtot=(Vmax/Vmin)).
  • Based on the previous input data and constraints the DPD strategy provides the injection-dwell-extraction through the following iterative relations. The first set is used to choose the dwell times T D(i) of the DPD pattern as follows:
  • { TD ( i + 1 ) = ( α + γ i ) TD ( i ) , i = 1 , , N - 1 TD ( 1 ) = T tot - 2 V tot q 1 + j = 1 N - 2 i = 1 j α + γ i
  • where,
      • α is the parameter which fix a base for the ratio T D(i+1)/T D(i), β is the parameter which allows to change the ratio T D(i+1)/T D(i) with respect the number of the cycle,
      • TD(1) is computed to respect the total therapy time Ttot
  • The second set is used to choose the volumes injected DV(i) of the DPD pattern as follows
  • { DV ( i + 1 ) = ( β + δ i ) DV ( i ) , i = 1 , , N - 2 DV ( 1 ) = V tot 1 + j = 1 N - 2 i = 1 j β + δ i
  • where,
      • β is the parameter which fix a base for the ratio DV(i+1)=DV (i),
      • δ is the parameter which allows to change the ratio DV(i+1)=DV (i) with respect the number of the cycle
      • V D(1) is computed to respect the total dialysate volume Vtot available. If γ=0, α=1 we obtain TD(i+1)=TD(i) and If δ=1, β=1 we obtain DV (i+1)=DV (i). This parameters set up allows to obtain standard treatments by the DPD methodology.
  • In order to guarantee the execution of the DPD pattern to pumping means the outputs produced are:
      • the dwell sequence T D(i); i=1; . . . ; N,
      • the volume sequence DV(i); i=1; . . . ; N−1,
      • the switching sequence for the pumping means execution,

  • t0=0;

  • tk+1=tk+DT(k); k=0; . . . ; 3N+1
  • where DT (k) represent the time needed in each cycle for the injection phase, the dwell and the extraction phase.
  • Of course the invention is not limited to the above examples. For instance other equations can be used for defining the varying parameters TD and DV.

Claims (14)

1. Peritoneal dialysis system comprising pumping means, therapy data receiving means and processing means, said processing means being designed to process said therapy data and to impart a switching sequence to said pumping means characterized by the fact that said processing means are furthermore designed to impart a specific exchange profile for each exchange cycle.
2. Peritoneal dialysis system according to claim 1 wherein said processing means are designed to vary the volume of liquid injected in each exchange cycle.
3. Peritoneal dialysis system according to claim 1 wherein said processing means are designed to vary the volume of liquid extracted in each exchange cycle.
4. Peritoneal dialysis system according to claim 1 wherein said processing means are designed to vary the dwell time in each exchange cycle.
5. Peritoneal dialysis system according to claim 1 wherein said therapy data include the total therapy time (Ttot), the total dialysate volume available for the peritonal dialysis session (Vtot), the flow rate of the pumping means (q), the maximum dialysate volume that can be contained in the peritoneal cavity (Vmax), the minimum dialysate volume reachable in the peritoneal cavity (Vmin) and the number of cycles of the therapy (N).
6. Peritoneal dialysis system according to claim 1 wherein said processing means are capable to determine each dwell time TD(i) according to the following system of equations:
{ TD ( i + 1 ) = ( α + γ i ) TD ( i ) , i = 1 , , N - 1 TD ( 1 ) = T tot - 2 V tot q 1 + j = 1 N - 2 i = 1 j α + γ i
where,
α is the parameter which fixes a base for the ratio T D(i+1)/T D(i), D is the parameter which allows to change the ratio T D(i+1)/T D(i) with respect the number of the cycle,
TD(1) is computed to respect the total therapy time Ttot.
7. Peritoneal dialysis system according to claim 1 wherein said processing means are capable to determine each volume injected DV(i) according to the following system of equations:
{ DV ( i + 1 ) = ( β + δ i ) DV ( i ) , i = 1 , , N - 2 DV ( 1 ) = V tot 1 + j = 1 N - 2 i = 1 j β + δ i
where,
β is the parameter which fix a base for the ratio DV(i+1)=DV (i),
δ is the parameter which allows to change the ratio DV(i+1)=DV (i) with respect the number of the cycle.
V D(1) is computed to respect the total dialysate volume Vtot available.
8. Peritoneal dialysis system according to claim 1 claims wherein said processing means are designed to determine the switching sequence as follows:

t0=0,

t k+1 =t k +DT(k); K=0; . . . ; 3N+1
where DT(k) represents the time needed in each exchange cycle for the injection phase, the dwell and the extraction phase.
9. Method for determining a peritoneal dialysis treatment characterized by the fact that the liquid exchange profile is varying from one exchange cycle to the other.
10. Method according to claim 9 wherein the dwell time TD varies from one exchange cycle to the other.
11. Method according to claim 9 wherein the volume of liquid injected DV varies from one exchange cycle to the other.
12. Method according to claim 9, wherein the volume of liquid extracted DV varies from one exchange cycle to the other.
13. Method according to claim 9 wherein each dwell time TD(i) is determined according to the following system of equations:
{ TD ( i + 1 ) = ( α + γ i ) TD ( i ) , i = 1 , , N - 1 TD ( 1 ) = T tot - 2 V tot q 1 + j = 1 N - 2 i = 1 j α + γ i
where,
α is the parameter which fixes a base for the ratio T D(i+1)/T D(i), β is the parameter which allows to change the ratio T D(i+1)/T D(i) with respect the number of the cycle,
TD(1) is computed to respect the total therapy time Ttot.
14. Method according to claim 8 wherein each volume injected DV(i) is determined according to the following system of equations:
{ DV ( i + 1 ) = ( β + δ i ) DV ( i ) , i = 1 , , N - 2 DV ( 1 ) = V tot 1 + j = 1 N - 2 i = 1 j β + δ i
where,
β is the parameter which fix a base for the ratio DV(i+1)=DV (i),
δ is the parameter which allows to change the ratio DV(i+1)=DV (i) with respect the number of the cycle.
V D(1) is computed to respect the total dialysate volume Vtot available.
US12/278,662 2006-02-08 2007-02-07 Peritoneal dialysis system Abandoned US20090187139A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/250,345 US9471754B2 (en) 2006-02-08 2014-04-10 Peritoneal dialysis system

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2006050412 2006-02-08
IB2006/050412 2006-02-08
PCT/IB2007/050406 WO2007091217A1 (en) 2006-02-08 2007-02-07 Peritoneal dialysis system

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/IB2007/050406 A-371-Of-International WO2007091217A1 (en) 2006-02-08 2007-02-07 Peritoneal dialysis system
PCT/IB2007/050596 A-371-Of-International WO2007099486A1 (en) 2006-03-01 2007-02-24 Guard interval lenght selection in an ofdm system based on coherence bandwith of the channel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/287,939 Division US8696613B2 (en) 2006-02-08 2011-11-02 Peritoneal dialysis system

Publications (1)

Publication Number Publication Date
US20090187139A1 true US20090187139A1 (en) 2009-07-23

Family

ID=38080801

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/278,662 Abandoned US20090187139A1 (en) 2006-02-08 2007-02-07 Peritoneal dialysis system
US13/287,939 Expired - Fee Related US8696613B2 (en) 2006-02-08 2011-11-02 Peritoneal dialysis system
US14/250,345 Expired - Fee Related US9471754B2 (en) 2006-02-08 2014-04-10 Peritoneal dialysis system

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/287,939 Expired - Fee Related US8696613B2 (en) 2006-02-08 2011-11-02 Peritoneal dialysis system
US14/250,345 Expired - Fee Related US9471754B2 (en) 2006-02-08 2014-04-10 Peritoneal dialysis system

Country Status (2)

Country Link
US (3) US20090187139A1 (en)
WO (1) WO2007091217A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090275881A1 (en) * 2008-05-02 2009-11-05 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US20100010425A1 (en) * 2008-07-09 2010-01-14 Baxter International Inc. Peritoneal equilibration test and dialysis system using same
US20100198138A1 (en) * 2009-01-30 2010-08-05 Baxter International Inc. Transfer sets for therapy optimization
US20100217178A1 (en) * 2009-02-20 2010-08-26 Baxter International Inc. Prediction of peritoneal dialysis therapy outcomes using dialysates mixed at different glucose concentrations
US20100298662A1 (en) * 2009-05-20 2010-11-25 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US20110093294A1 (en) * 2009-10-16 2011-04-21 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
US8871095B2 (en) 2008-07-09 2014-10-28 Baxter International Inc. Dialysis method including wireless patient data
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US9649436B2 (en) 2011-09-21 2017-05-16 Bayer Healthcare Llc Assembly method for a fluid pump device for a continuous multi-fluid delivery system
US10507319B2 (en) 2015-01-09 2019-12-17 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US10702645B2 (en) * 2009-01-29 2020-07-07 Baxter International Inc. Drain and fill logic for automated peritoneal dialysis

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US8142649B2 (en) * 2009-01-29 2012-03-27 Baxter International Inc. Method for optimizing tidal therapies employing ultrafiltrate trending
US8868350B2 (en) 2010-04-16 2014-10-21 Baxter International Inc. Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
US8936720B2 (en) * 2010-09-17 2015-01-20 Baxter International Inc. Drain and fill logic for automated peritoneal dialysis
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
GB2503162B (en) 2011-03-23 2018-08-22 Nxstage Medical Inc Peritoneal dialysis systems and devices
DE102011105916B4 (en) 2011-06-29 2013-03-28 Fresenius Medical Care Deutschland Gmbh dialysis machine
DE102014013229A1 (en) * 2014-09-05 2016-03-10 Fresenius Medical Care Deutschland Gmbh Apparatus for performing a tidal peritoneal dialysis treatment
EP4445924A2 (en) 2016-09-02 2024-10-16 Baxter International Inc. Apparatus for providing automated peritoneal dialysis
RO132971A2 (en) 2017-06-12 2018-12-28 Fresenius Medical Care Deutschland Gmbh Method and apparatus for generating a treatment regimen
EP3641850B1 (en) 2017-06-24 2024-10-09 NxStage Medical Inc. Peritoneal dialysis fluid preparation systems
US11872337B2 (en) 2018-02-28 2024-01-16 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems
US20240096472A1 (en) * 2022-09-20 2024-03-21 Medtronic Navigation, Inc. Robotically-assisted drug delivery

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558343B1 (en) * 1998-04-02 2003-05-06 Debiotech S.A. Device for peritoneal dialysis and method for using said device

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835175B1 (en) * 1998-04-10 2004-12-28 Proactive Metabolics Co. Medical devices for contemporaneous decision support in metabolic control
US6497676B1 (en) * 2000-02-10 2002-12-24 Baxter International Method and apparatus for monitoring and controlling peritoneal dialysis therapy
SE0001939D0 (en) * 2000-05-25 2000-05-25 Gambro Lundia Ab Medical solution and use thereof
US20030216677A1 (en) * 2002-05-15 2003-11-20 Li Pan Biosensor for dialysis therapy
BRPI0413074A (en) * 2003-07-31 2006-10-03 Debiotech Sa system for peritoneal dialysis
WO2005035023A1 (en) * 2003-10-13 2005-04-21 Gambro Lundia Ab A device for carrying out a peritoneal dialysis treatment
EP2381376A1 (en) * 2010-04-22 2011-10-26 Debiotech S.A. Peritoneal dialysis prescription system and method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558343B1 (en) * 1998-04-02 2003-05-06 Debiotech S.A. Device for peritoneal dialysis and method for using said device

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US20090275881A1 (en) * 2008-05-02 2009-11-05 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US9348975B2 (en) 2008-05-02 2016-05-24 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US8871095B2 (en) 2008-07-09 2014-10-28 Baxter International Inc. Dialysis method including wireless patient data
US10307524B2 (en) 2008-07-09 2019-06-04 Baxter International Inc. Dialysis method and system including wireless patient data
US10272190B2 (en) 2008-07-09 2019-04-30 Baxter International Inc. Renal therapy system including a blood pressure monitor
US10016554B2 (en) 2008-07-09 2018-07-10 Baxter International Inc. Dialysis system including wireless patient data
US10265455B2 (en) 2008-07-09 2019-04-23 Baxter International Inc. Dialysis system including wireless sensor data
US9147045B2 (en) 2008-07-09 2015-09-29 Baxter International Inc. Peritoneal equilibration test and dialysis system using same
US20100010425A1 (en) * 2008-07-09 2010-01-14 Baxter International Inc. Peritoneal equilibration test and dialysis system using same
US10702645B2 (en) * 2009-01-29 2020-07-07 Baxter International Inc. Drain and fill logic for automated peritoneal dialysis
US8377012B2 (en) 2009-01-30 2013-02-19 Baxter International Inc. Transfer sets for therapy optimization
US8636706B2 (en) 2009-01-30 2014-01-28 Baxter International Inc. Transfer sets for therapy optimization
US20100198138A1 (en) * 2009-01-30 2010-08-05 Baxter International Inc. Transfer sets for therapy optimization
US20100217178A1 (en) * 2009-02-20 2010-08-26 Baxter International Inc. Prediction of peritoneal dialysis therapy outcomes using dialysates mixed at different glucose concentrations
US9381290B2 (en) 2009-05-20 2016-07-05 Baxter International Inc. System and method for pairing a dialysis machine with peripheral devices
US11027053B2 (en) 2009-05-20 2021-06-08 Baxter International Inc. Method for pairing a dialysis machine with peripheral devices
US11752245B2 (en) 2009-05-20 2023-09-12 Baxter International Inc. System and method for automated collection of dialysis data
US20100298662A1 (en) * 2009-05-20 2010-11-25 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US8282829B2 (en) 2009-05-20 2012-10-09 Baxter International Inc. System and method for automated data collection of twenty-four hour ultrafiltration and other patient parameters using wired or wireless technology
US10314958B2 (en) 2009-05-20 2019-06-11 Baxter International Inc. System and method for pairing a dialysis machine with peripheral devices
US20110093294A1 (en) * 2009-10-16 2011-04-21 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
US10449284B2 (en) * 2009-10-16 2019-10-22 Baxter Interntional Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US9020827B2 (en) 2009-10-16 2015-04-28 Baxter International Inc. Peritoneal dialysis optimized using a patient hand-held scanning device
US11058809B2 (en) * 2009-10-16 2021-07-13 Baxter International Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US20210338913A1 (en) * 2009-10-16 2021-11-04 Baxter International Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US11607479B2 (en) * 2009-10-16 2023-03-21 Baxter International Inc. Optimizing peritoneal dialysis using a patient hand-held scanning device
US9700672B2 (en) 2011-09-21 2017-07-11 Bayer Healthcare Llc Continuous multi-fluid pump device, drive and actuating system and method
US9649436B2 (en) 2011-09-21 2017-05-16 Bayer Healthcare Llc Assembly method for a fluid pump device for a continuous multi-fluid delivery system
US10507319B2 (en) 2015-01-09 2019-12-17 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US11491318B2 (en) 2015-01-09 2022-11-08 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof

Also Published As

Publication number Publication date
US8696613B2 (en) 2014-04-15
WO2007091217A1 (en) 2007-08-16
US20120143124A1 (en) 2012-06-07
US20140221910A1 (en) 2014-08-07
US9471754B2 (en) 2016-10-18

Similar Documents

Publication Publication Date Title
US20090187139A1 (en) Peritoneal dialysis system
US20190316948A1 (en) Medical treatment system and methods using a plurality of fluid lines
US8088094B2 (en) Planning method and apparatus for peritoneal dialysis and hemodialysis hybrid remedy
EP2990073A1 (en) Devices, systems and methods for fluid delivery
WO2016104720A1 (en) Blood treatment system
CN107441575A (en) Portable dialysis machine
KR20160047428A (en) Manifold diaphragms
Al-Helali et al. Novel molecular signaling method and system for molecular communication in human body
US11806456B2 (en) Precision peritoneal dialysis therapy based on dialysis adequacy measurements
EP2381376A1 (en) Peritoneal dialysis prescription system and method
Lowrie The normalized treatment ratio (Kt/V) is not the best dialysis dose parameter
US11123464B2 (en) Calculating a depletion time during dialysis
CA3114879A1 (en) Infusion pump and infusion pump operations
US20200282125A1 (en) Individualized dialysis with inline sensor
MX2011008805A (en) Prediction of peritoneal dialysis therapy outcomes using dialysates mixed at different glucose concentrations.
JP2003275301A (en) Peritoneal dialysis system
Mateják Formalization of Integrative Physiology
CN110152116A (en) Infusion control method, device, terminal and computer readable storage medium
Ortiz-Leon et al. An Updated Cardiovascular Simulation Toolbox
CA3163697A1 (en) Individualized dialysis with inline sensor
Harrod A Non-Invasive Patient-Specific Modeling Approach for Predicting Group II Pulmonary Hypertension as a Clinical Indicator of Diastolic Heart Failure for Patients with Uncertain Clinical Data
Mandyam et al. Compositional Q-learning for electrolyte repletion with imbalanced patient sub-populations
Pereda Sebastián Methods for the treatment of uncertainty in dynamical systems: Application to diabetes
Ronco et al. Integration of peritoneal dialysis in the treatment of uremia
Akonur et al. A Mathematical Model to Optimize the Drain Phase in Gravity-Based Peritoneal Dialysis Systems

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEBIOTECH S.A., SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MASTALLI, DIEGO;QUARTERONI, ALFIO;ZUNINO, PAOLO;REEL/FRAME:021959/0965

Effective date: 20080812

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION